Experts Push Expanded ‘March-In Rights’ As Way To Bring Down Prices

During an all-day public meeting on the Hatch-Waxman drug patent law and how FDA could help bring down drug prices by speeding generics to market, one presenter raised the idea of expanding the Bayh-Dole Act's march-in rights to cover any product regulated by FDA as a way to rein in prices -- an idea the agency noted “would be of interest.” Meeting presenters -- including academics and researchers, generic drug makers, pharmaceutical industry groups, payers and patient representatives -- also...